Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues

Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues—authors' reply

Published:2023-02-14 Issue:5 Volume:57 Page:583-584
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Wagner Josef¹²,Littlejohn Margaret¹³,Revill Peter A.¹³^ORCID

Affiliation:

1. Victorian Infectious Diseases Reference Laboratory Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity Melbourne Victoria Australia

2. Department of Paediatrics University of Melbourne Melbourne Victoria Australia

3. Department of Infectious Diseases University of Melbourne at the Peter Doherty Institute for Infection and Immunity Melbourne Victoria Australia

Abstract

LINKED CONTENTThis article is linked to Wagner et al papers. To view these articles, visit https://doi.org/10.1111/apt.17299 and https://doi.org/10.1111/apt.17328

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17364

Reference8 articles.

1. Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues;Li Y‐J;Aliment Pharmacol Ther,2023

2. Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes a and D HBeAg‐positive chronic hepatitis B;Wagner J;Aliment Pharmacol Ther,2023

3. Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection—Lessons for Functional HBV Cure?

4. Pregenomic HBV RNA and Hepatitis B Core‐Related Antigen Predict Outcomes in Hepatitis B e Antigen–Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy

5. Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation